CCCC - C4 Therapeutics, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.04 0.14 (6.86%)	---	---	---	-0.02 (-0.98%)	0.2 (9.95%)	-0.04 (-1.77%)	-0.04 (-1.77%)

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.37
Diluted EPS:: -0.37
Basic P/E:: -5.8919
Diluted P/E:: -5.8919
RSI(14) 1m:: 100.0
VWAP:: 2.18
RVol:: 0.5039

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	2.12 +0.06 (+3.16%)	Oct 15 09:59
10m	Price increase 10m	2.08 +0.07 (+3.23%)	Oct 15 09:36
1m	Price increase 1m	2.06 +0.05 (+2.24%)	Oct 15 09:30